Soft Tissue Lesion clinical trials at University of California Health
2 research studies open to eligible people
PET [89Zr]DFO-starPEG in Solid Tumors
open to eligible people ages 18 years and up
This is a first-in-human, pilot study of the novel PET-imaging radiotracer [89Zr]DFO-starPEG. The study is designed to obtain preliminary data to support future development of this agent as an imaging surrogate to visualize enhanced permeability and retention (EPR)-mediated tracer uptake before administration of EPR-based nanomedicines.
at UCSF
Registry of Histotripsy for Soft Tissue Tumors
open to eligible people ages 18 years and up
Histotripsy is a treatment that uses focused ultrasound waves to break down tissue without surgery. The ultrasound waves meet at a specific spot and turn the tissue into liquid. This study is a prospective observational registry of participants receiving histotripsy. The goal of this study is to gather information about the use of histotripsy to confirm it is safe and effective medical procedure.
at UCSF
Our lead scientists for Soft Tissue Lesion research studies include Robert Flavell, MD, PhD.
Last updated: